Instrumento Inactivo

Otros idiomas SciBase Holding AB (publ)

Acciones

Precio de cierre Nasdaq Stockholm Otros sitios de cotización
- ^SEK	-

05/04	SciBase planea una captación de capital de 48 millones de coronas suecas para su comercialización y crecimiento en EE.UU.	MT
28/02	SciBase ofrecerá una herramienta de diagnóstico en la plataforma de pruebas cosméticas Skinobs	MT

Last day of trading in unit rights in SciBase rights issue	02/05
SciBase supports clinicians during US Skin Cancer Awareness Month	02/05
SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE	24/04
SciBase will present at the Redeye Medtech Event on April 24[th]	23/04
Today is the first day of the subscription period in SciBase rights issue	23/04
SciBase publishes prospectus in connection with upcoming rights issue	19/04
Notice to extraordinary general meeting in Scibase Holding AB (publ)	08/04
SciBase Plans SEK48 Million Capital Raising for Commercialization, Growth in US	05/04
SciBase resolves on a directed issued of approximately SEK 33 million and a rights issue of approximately SEK 15 million	05/04
SciBase to Offer Diagnostic Tool on Skinobs Cosmetic Testing Platform	28/02
SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform	28/02
Scibase Q4’23 - Investments for future growth	22/02
Year-end report	21/02
Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami	19/02
New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL	16/02
Sweden's Scibase Partners with Inderes for Equity Research	30/01
SciBase initiates collaboration with Inderes for commissioned research	30/01
Welcome to SciBase Capital Markets Day 2024	26/01
Letter from the CEO	10/01
Welcome to SciBase Capital Markets Day 2024	09/01

No hay resultados para esta búsqueda